There is ongoing clinical need to improve estimates of disease outcome in prostate cancer. Machine learning (ML) approaches to pathologic diagnosis and prognosis are a promising and increasingly used ...
In patients with a high suspicion of prostate cancer as determined by molecular imaging, avoiding biopsy prior to radical prostatectomy appeared to be feasible, and "might represent a valid option in ...
SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the validation of its first multimodal artificial ...
Prostate cancer is among the most diagnosed cancers, accounting for 26% of new cancer diagnoses in men in 2021. 1 An important factor in understanding prostate cancer prognosis is the risk of clinical ...
Pathologic concordance between prostate biopsy and radical prostatectomy improves with use of a novel robotic-assisted transperineal fusion biopsy platform. Optimization of risk stratification at ...
Real-world data do not support discontinuing prostate cancer active surveillance for radical treatment without clear evidence of progression. Real-world data show that discontinuing prostate cancer ...
Dr. Patrick Walsh answers the question: 'Perineal Vs. Retropubic Approach?' March 16, 2009 -- Question: What are the differences between a radical perineal prostatectomy and a radical retropubic ...
The median fraction of the gland reaching ablative temperatures on intra-procedural MRI thermometry was 78% (IQR 71-85), with 68% of cases comprising whole gland ablation and 32% sub-total ablation: ...
MINNEAPOLIS, Feb. 14, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced an important publication in World Journal of Urology, entitled Pre–diagnosis urine exosomal RNA (ExoDx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results